(Total Views: 63)
Posted On: 05/17/2019 10:47:03 AM
Post# of 44089
$BIXT announced that it has retained Juan Carlos Lopez-Talavera, MD, PhD to join Bioxytran’s Scientific Advisory Board to manage the company’s FDA regulatory application process for Bioxytran’s flagship drug, BXT-25. https://finance.yahoo.com/news/bioxytran-inc-...26145.html
(0)
(0)
